Investment Team

Active Responsibilities
Select Prior Responsibilities

Richard S. Kollender

  • Joined Quaker Partners in 2003 and promoted to Partner in 2005
  • Previously: Held positions in sales, marketing and worldwide business development at GlaxoSmithKline. Also served as investment manager at S.R. One where he evaluated potential investment opportunities, performed due diligence, structured and negotiated investments and worked with management teams to execute their strategies following investment. Began his career as a CPA with KPMG Peat Marwick with an emphasis on the healthcare and emerging businesses sectors.
  • Active Responsibilities: Horizon Pharma, Insmed, Rapid Micro Biosystems and Tarsa Therapeutics
  • Select Prior Responsibilities: Achillion Pharmaceuticals (Nasdaq: ACHN), Medmark (acquired by Walgreen Co.) and NuPathe (acquired by Teva)
  • Other: Public Policy Committee Member for Pennsylvania Bio. Certified Public Accountant. Member of both the American and Pennsylvania Institutes of Certified Public Accountants. Adjunct faculty, Lehigh University.
  • Education: B.A. from Franklin and Marshall College, M.B.A. and Health Administration & Policy degrees with Honors from the University of Chicago